AUTHERA AS
928956164ActiveDeveloping novel FcRn-targeting biologics for therapeutic applications.
Oversigt
- 5
- Medarbejdere
- 10.6mio NOK
- Omsætning
- 2022
- Grundlagt
Nøglebeslutningstagere
Gaia Calamera
Lead Senior Scientist
Inger Sandlie
Board member & Co-founder
Torleif T. Gjølberg
CSO & Co-founder
Simone Mester
CEO & Co-founder
+5 flere kontakter i Funnelfeedr
Beskrivelse
Authera is a pre-clinical biotechnology company established in 2022 as a spin-off from Oslo University Hospital and the University of Oslo. The organization is dedicated to developing novel therapeutic biologics based on proprietary research into albumin and antibody-based molecules. Their core asse...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- Aksjeselskap
- Momsnummer
- Ukendt
Beslutningstagere
9 kontakter i FunnelfeedrGaia Calamera
Lead Senior Scientist
Inger Sandlie
Board member & Co-founder
Torleif T. Gjølberg
CSO & Co-founder
Simone Mester
CEO & Co-founder
Jan Terje Andersen
Chairman & Co-founder
Hans Petter Tjeldflaat
CFO
Andre kontakter
Eirik Sundlisæter
Medical Advisor
Jenny Skjermo Telstad
Associate Scientist
Milena A. Blaga
Senior Scientist
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrPFIZER GLOBAL TRADING
Leading global biopharmaceutical company developing life-changing medicines and vaccines.
OxThera Intellectual Property AB
0 medarbejdereDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
OxThera AB
0 medarbejdereDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Sixera Pharma AB
1–4 medarbejdereSmall biotech developing first treatment for rare Netherton syndrome.
QureTech Bio AB
5–9 medarbejdereDeveloping novel synthetic antibiotics to combat drug-resistant bacteria.
Udforsk mere
Spørgsmål om AUTHERA AS
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo